Similarly, mutagenesis by these agents was also enhanced following CRISPR/Cas9 gene editing of the ATM substrate p53, an important regulator of cell cycle arrest, senescence and apoptosis, or over expression of a cancer-associated p53 mutant. The gene discussed is ATM; the disease is cancer.